InvestorsHub Logo
Followers 105
Posts 2892
Boards Moderated 0
Alias Born 09/16/2011

Re: None

Tuesday, 10/14/2014 11:40:09 AM

Tuesday, October 14, 2014 11:40:09 AM

Post# of 263759
Perspective: This drop in the value of GRCU since the April '14 peak is very painful, no doubt. But I highly disagree with the narrative that this is evidence that Robert Calkin has failed as a CEO. While we have dropped quite a bit since the April peak, the stock is still up a great deal from where it was trading when it bottomed in late 2013. And by a great deal higher, I am referring to the fact that as of today, GRCU is still 60-70 times where it was at, less than 1 year ago, when it bottomed at .0001. That is 6000% - 7000% higher than the bottom.

I know this is of little consolation to those that bought at much higher levels. But when viewed objectively, it is more supportive of a narrative that Robert Calkin has accomplished a great deal as the CEO of Green Cures (GRCU). And that many shareholders believe that he will continue on that path. I believe that the drifting downward of the share price, since the multi-penny peak, is more a reflection of what typically happens in the OTC market after nearly every since run.

I am one of those shareholders that believes in Robert's ability and commitment to accomplish a great deal with respect to Green Cures, and that is why I remain a long term holder of GRCU shares.

As always, simply my opinion.



GRCU